FTAI is up +138.36% since Oct ’23 pick Unlock All Top Buy Picks

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of TOVX
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Big movements in Theriva Biologics, Inc. stock price on Friday moving 11.64% between high and low
(Updated on May 31, 2024)

Sell candidate since Apr 19, 2024 Loss -39.76% PDF

The Theriva Biologics, Inc. stock price fell by -6.43% on the last day (Friday, 31st May 2024) from $0.267 to $0.250. During the last trading day the stock fluctuated 11.64% from a day low at $0.250 to a day high of $0.279. The price has fallen in 8 of the last 10 days and is down by -33.13% for this period. Volume has increased on the last day by 119 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 348 thousand shares were bought and sold for approximately $87.01 thousand.

Given the current short-term trend, the stock is expected to fall -27.07% during the next 3 months and, with a 90% probability hold a price between $0.182 and $0.346 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

TOVX Signals & Forecast

There are few to no technical positive signals at the moment. The Theriva Biologics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.295 and $0.381. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, March 20, 2024, and so far it has fallen -59.48%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Theriva Biologics, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Theriva Biologics, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0291 between high and low, or 11.64%. For the last week, the stock has had daily average volatility of 16.13%.

Theriva Biologics, Inc. is oversold on RSI14 (14). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (TOVX) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Theriva Biologics, Inc. to open at $0.260, and during the day (based on 14 day Average True Range), to move between $0.208 and $0.292, which gives a possible trading interval of +/-$0.0419 (+/-16.74%) up or down from last closing price. If Theriva Biologics, Inc. takes out the full calculated possible swing range there will be an estimated 33.47% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.271, some $0.0209 (8.36%) from the current price of $0.250, our system finds the risk reward not very attractive.

Is Theriva Biologics, Inc. stock A Buy?

Theriva Biologics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -6.125 Strong Sell Candidate Unchanged

Predicted Opening Price for Theriva Biologics, Inc. of Monday, June 3, 2024

Fair opening price June 3, 2024 Current price
$0.260 ( 3.88%) $0.250

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for TOVX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.289 15.51 %
R2 0.278 11.07 %
R1 0.271 8.32 %
Current price: 0.250
Support S1 0.249 -0.566 %
S2 0.242 -3.31 %
S3 0.231 -7.76 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.306 22.35 %
R2 0.279 11.56 %
R1 0.271 8.36 %
Current price 0.250
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Theriva Biologics, Inc. Stock and on which exchange is it traded?
The symbol for Theriva Biologics, Inc. is TOVX and it is traded on the NYSEMKT (NYSE American).

Should I buy or sell Theriva Biologics, Inc. Stock?
Theriva Biologics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Theriva Biologics, Inc. Stock?
Theriva Biologics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Theriva Biologics, Inc. Stock.

What's the current price of Theriva Biologics, Inc. Stock?
As of the end of day on the May 31, 2024, the price of an Theriva Biologics, Inc. (TOVX) share was $0.250.

What is the 52-week high and low for Theriva Biologics, Inc. Stock?
The 52-week high for Theriva Biologics, Inc. Stock is $1.20 and the 52-week low is $0.197.

What is the market capitalization of Theriva Biologics, Inc. Stock?
As of the May 31, 2024, the market capitalization of Theriva Biologics, Inc. is 4.618M.

When is the next earnings date for Theriva Biologics, Inc.?
The upcoming earnings date for Theriva Biologics, Inc. is Aug 06, 2024.
Click to get the best stock tips daily for free!